Acute kidney injury with sodium‐glucose co‐transporter‐2 inhibitors: A meta‐analysis of cardiovascular outcome trials-Reference-Cited by-同舟云学术

Acute kidney injury with sodium‐glucose co‐transporter‐2 inhibitors: A meta‐analysis of cardiovascular outcome trials

Published:2019-08 Issue:8 Volume:21 Page:1996-2000
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Gilbert Richard E.¹^ORCID,Thorpe Kevin E.²³

Affiliation:

1. Division of EndocrinologyKeenan Research Centre, Li Ka Shing Knowledge Institute, St. Michael's Hospital Toronto Ontario Canada

2. Dalla Lana School of Public HealthUniversity of Toronto Toronto Ontario Canada

3. Applied Health Research CentreSt. Michael's Hospital Toronto Ontario Canada

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.13754

Reference28 articles.

1. FDA. FDA strengthens kidney warnings for diabetes medicines canagliflozin (Invokana Invokamet) and dapagliflozin (Farxiga Xigduo XR).2016.https://www.fda.gov/downloads/Drugs/DrugSafety/UCM506772.pdf. Accessed March 16 2019.

2. Acute Kidney Injury Predicts Major Adverse Outcomes in Diabetes: Synergic Impact With Low Glomerular Filtration Rate and Albuminuria

3. Acute kidney injury from SGLT2 inhibitors: potential mechanisms

4. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

5. Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sodium-Glucose Cotransporter 2 Therapy for Acute Organ Dysfunction in Critically Ill Patients;JAMA;2024-08-06

2. The Effect of Sodium Glucose Cotransporter‐2 Inhibitors on Hemoglobin A1c Variability and Acute Kidney Injury: A Causal Mediation Analysis;Pharmacoepidemiology and Drug Safety;2024-08

3. State-of-the-Art-Review: Mechanisms of Action of SGLT2 Inhibitors and Clinical Implications;American Journal of Hypertension;2024-07-17

4. Effects of sodium-glucose transporter-2 inhibition on systemic hemodynamics, renal function, and intra-renal oxygenation in sepsis-associated acute kidney injury;Intensive Care Medicine Experimental;2024-07-08

5. Impact of SGLT2 Inhibitors on Renal Function in Type 2 Diabetic Patients with Coronary Artery Disease Undergoing Percutaneous Intervention: A Systematic Review and Meta-Analysis;Current Diabetes Reviews;2024-07-03